- Report
- January 2026
- 196 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- November 2025
- 185 Pages
Global
From €3906EUR$4,500USD£3,387GBP
- Report
- January 2026
- 181 Pages
Global
From €3906EUR$4,500USD£3,387GBP
- Report
- January 2026
- 468 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 681 Pages
Global
From €6072EUR$6,995USD£5,264GBP
- Report
- November 2025
- 150 Pages
Global
From €5165EUR$5,950USD£4,478GBP
- Report
- November 2025
- 150 Pages
Global
From €5165EUR$5,950USD£4,478GBP
- Report
- April 2025
- 180 Pages
Global
From €5165EUR$5,950USD£4,478GBP
- Report
- January 2026
- 194 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 185 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 196 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 198 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 187 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 196 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 183 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 184 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 198 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- January 2026
- 185 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- November 2025
- 198 Pages
Global
From €3419EUR$3,939USD£2,964GBP
- Report
- October 2025
- 195 Pages
Global
From €3419EUR$3,939USD£2,964GBP

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research.
Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more